Fast-Paced Growth Ahead for Peripheral Vascular Device Market by...

Fast-Paced Growth Ahead for Peripheral Vascular Device Market by 2034

Posted 2025-05-19 12:36:47

110

The global Peripheral Vascular Device Market is on a robust growth trajectory, driven by the increasing incidence of peripheral artery disease (PAD), advancements in endovascular therapy, and the growing preference for minimally invasive surgical procedures. These trends are further reinforced by the aging global population and increasing healthcare expenditure.

Global Peripheral Vascular Device Market size and share is currently valued at USD 10.67 billion in 2024 and is anticipated to generate an estimated revenue of USD 18.51 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034

Market Overview

Peripheral vascular devices are critical tools in diagnosing and treating diseases affecting blood vessels outside the heart and brain, particularly those in the lower extremities. The market encompasses a broad range of products including angioplasty balloons, stents, catheters, atherectomy devices, vascular grafts, vena cava filters, and hemodynamic flow systems.

The rise in lifestyle-related diseases, such as diabetes, obesity, and hypertension, has contributed to an increased burden of PAD globally. According to the World Health Organization, over 200 million people suffer from PAD, with a significant portion undiagnosed due to asymptomatic progression. As awareness and diagnostic capabilities improve, so does the demand for peripheral vascular interventions.

Key Market Growth Drivers

1. Rising Prevalence of PAD and Chronic Diseases

The increasing global burden of PAD, particularly among elderly and diabetic populations, is one of the primary growth drivers. The chronic nature of vascular diseases necessitates long-term treatment and periodic surgical interventions, spurring demand for durable and efficient vascular devices.

2. Technological Advancements in Device Design

Ongoing R&D efforts have led to innovations such as drug-eluting stents, bioresorbable scaffolds, and advanced atherectomy systems. These innovations enable more precise and safer interventions, improving patient outcomes and reducing hospital stays.

3. Growing Preference for Minimally Invasive Procedures

Minimally invasive surgeries reduce recovery time, risk of complications, and overall healthcare costs. As patient awareness grows and hospital systems seek cost-effective care models, demand for endovascular procedures using peripheral devices continues to rise.

4. Expanding Healthcare Access in Emerging Economies

Governments in Asia-Pacific, Latin America, and the Middle East are investing heavily in expanding access to healthcare. New hospitals, improved diagnostic capabilities, and growing physician training programs are driving device adoption in previously underserved markets.

Market Challenges

1. High Cost of Advanced Devices and Procedures

The cost of technologically advanced vascular devices, especially drug-coated products, can be prohibitive for patients and healthcare systems in low- and middle-income countries. Limited reimbursement options and budget constraints in public hospitals act as barriers to market penetration.

2. Regulatory Complexities and Approval Delays

Peripheral vascular devices are subject to stringent regulatory scrutiny due to the critical nature of their applications. Securing approvals from agencies such as the FDA or EMA can be time-consuming and resource-intensive, particularly for smaller manufacturers.

3. Risk of Complications and Recurrence

Despite technological advances, peripheral vascular procedures carry risks such as restenosis, embolism, or device failure. Concerns about long-term safety and efficacy can hinder adoption rates, especially for newer products.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/global-peripheral-vascular-device-market

Regional Analysis

North America

North America remains the largest market for peripheral vascular devices, accounting for more than 35% of the global share in 2024. The United States leads with high diagnosis rates of PAD, favorable reimbursement policies, and widespread adoption of minimally invasive technologies. The presence of major industry players and research institutions fosters continuous innovation and rapid commercialization of advanced devices.

Europe

Europe is the second-largest market, with countries like Germany, France, and the UK at the forefront. The region benefits from universal healthcare systems and government funding for PAD treatment programs. Aging populations and increased focus on early diagnosis and outpatient care are further contributing to demand.

Asia-Pacific

The Asia-Pacific region is expected to witness the fastest growth over the forecast period. Rapid urbanization, rising income levels, and increasing prevalence of diabetes and obesity are driving the incidence of vascular diseases. Countries like China, India, and Japan are investing in healthcare modernization and offering incentives for local manufacturing of medical devices.

Latin America

Latin America is emerging as a promising market, particularly in Brazil and Mexico. Government partnerships with international healthcare companies and rising public awareness about vascular diseases are catalyzing growth. However, high out-of-pocket expenses remain a concern.

Middle East and Africa

The MEA region is gradually adopting peripheral vascular technologies, especially in Gulf Cooperation Council (GCC) countries. Healthcare reforms and the establishment of specialized vascular centers in Saudi Arabia and the UAE are encouraging market entry. Limited access in sub-Saharan Africa still hampers growth.

Key Companies in the Peripheral Vascular Device Market

1. Medtronic plc (Ireland)

Medtronic is a global leader in vascular solutions, offering a wide range of devices including drug-eluting balloons, stent grafts, and embolization devices. Its IN.PACT Admiral drug-coated balloon is one of the most widely used in PAD interventions.

2. Boston Scientific Corporation (USA)

Boston Scientific provides a comprehensive portfolio of peripheral vascular products. Its Jetstream Atherectomy System and Eluvia Drug-Eluting Stent System are popular in both U.S. and international markets.

3. Abbott Laboratories (USA)

Abbott offers advanced stents, guidewires, and balloons through its vascular division. The Supera Peripheral Stent System is known for high durability and flexibility in treating complex PAD cases.

4. Becton, Dickinson and Company (USA)

BD, following its acquisition of Bard, offers a full suite of peripheral vascular products including angioplasty catheters, venous stents, and vascular access devices. The company continues to innovate in minimally invasive therapy solutions.

5. Terumo Corporation (Japan)

Terumo has a strong presence in both coronary and peripheral intervention markets. Its Glidewire technology and Misago stent systems are widely used in Asia and expanding into Western markets.

6. Cook Medical (USA)

Cook specializes in interventional radiology and vascular access, with strengths in embolization, thrombectomy, and catheter-based interventions. It is noted for its commitment to clinician education and device customization.

7. Cardinal Health (USA)

While primarily known for distribution, Cardinal Health manufactures a variety of vascular devices and offers integrated supply chain services. The company plays a critical role in enabling small hospitals and outpatient centers to access peripheral vascular technologies.

8. Koninklijke Philips N.V. (Netherlands)

Philips has expanded into peripheral vascular solutions through its acquisition of Spectranetics. The Stellarex DCB and laser atherectomy platforms are central to its endovascular portfolio.

9. Biotronik SE & Co. KG (Germany)

Biotronik offers innovative stent and catheter systems with a strong focus on long-term clinical data. Its Passeo series of balloons and stents are widely adopted in European and emerging markets.

10. Endologix LLC (USA)

Specializing in endovascular aneurysm repair (EVAR), Endologix provides highly differentiated solutions for treating complex aortic conditions. Its AFX2 system is a benchmark in aneurysm treatment.

Conclusion

The Peripheral Vascular Device Market is entering a dynamic phase of innovation and adoption, driven by the global rise in chronic vascular diseases, advances in minimally invasive technology, and supportive healthcare policies. While regulatory and economic challenges persist, the long-term outlook remains positive due to growing investment in research, training, and infrastructure.

As emerging markets begin to mirror the diagnostic and interventional capabilities of developed regions, the stage is set for global expansion and improved patient outcomes. Key players are likely to pursue strategic collaborations, clinical trials, and regional manufacturing to sustain competitiveness and meet growing demand.

With vascular health becoming a critical focus of public health policy and clinical research, the peripheral vascular device industry is positioned not only for commercial success but also for delivering substantial societal impact.

More Trending Reports by Polaris Market Research:

Apheresis Equipment Market

Autoimmune Disease Diagnostics Market

Optical Coherence Tomography (Oct) Market

Pruritus Therapeutics Market

Hemodynamic Monitoring Devices Market

Narcolepsy Therapeutics Market

Asthma Treatment Market

Bipolar Disorder Treatment Market

Facial Injectable Market

Brain Tumor Diagnosis and Therapeutics Market

Healthcare Cybersecurity Market